Bart Fevery
- Hepatology top 1%
- Epidemiology top 5%
- Infectious Diseases top 5%
- Rheumatology
- Molecular Biology
- Co-authors
- Oliver LenzMonika PeetersGastón PicchioLeen VijgenRonald KalmeijerSandra De MeyerGuy De La RosaJames Witek
- Topics
- Hepatitis C virus research (29 papers)Hepatitis B Virus Studies (16 papers)HIV/AIDS drug development and treatment (12 papers)
- Partner nations
- United StatesBelgiumGermany
In The Last Decade
Bart Fevery
35 papers receiving 937 citations
Peers
Comparison fields: 5 of 36
- Hepatology 928
- Epidemiology 849
- Infectious Diseases 317
- Rheumatology 74
- Molecular Biology 31
Countries citing papers authored by Bart Fevery
This map shows the geographic impact of Bart Fevery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Fevery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Fevery more than expected).
Fields of papers citing papers by Bart Fevery
This network shows the impact of papers produced by Bart Fevery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Fevery. The network helps show where Bart Fevery may publish in the future.
Co-authorship network of co-authors of Bart Fevery
This figure shows the co-authorship network connecting the top 25 collaborators of Bart Fevery. A scholar is included among the top collaborators of Bart Fevery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bart Fevery. Bart Fevery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 6 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study | 5 |
| 6 | 25 | |
| 7 | 2 | |
| 8 | 8 | |
| 9 | 63 | |
| 10 | 82 | |
| 11 | 142 | |
| 12 | 50 | |
| 13 | 110 | |
| 14 | 16 | |
| 15 | 69 | |
| 16 | 4 | |
| 17 | 21 | |
| 18 | TMC435 IN COMBINATION WITH PEGINTERFERON ALPHA-2A/RIBAVIRIN IN TREATMENT-NAiVE PATIENTS INFECTED WITH HCV GENOTYPE 1: VIROLOGY ANALYSIS OF THE PILLAR STUDY | 8 |
| 19 | 20 | |
| 20 | 3 |
About Bart Fevery
Bart Fevery is a scholar working on Hepatology, Infectious Diseases and Epidemiology, having authored 35 papers that have together received 949 indexed citations. Recurring topics across this work include Hepatitis C virus research (29 papers), Hepatitis B Virus Studies (16 papers) and HIV/AIDS drug development and treatment (12 papers). The work is most often cited by research in Hepatology (928 citations), Epidemiology (849 citations) and Infectious Diseases (317 citations). Bart Fevery has collaborated with scholars based in United States, Belgium and Germany. Frequent co-authors include Oliver Lenz, Monika Peeters, Gastón Picchio, Leen Vijgen, Ronald Kalmeijer, Sandra De Meyer, Guy De La Rosa, James Witek, Thierry Verbinnen and Rekha Sinha. Their work appears in journals such as Hepatology, Antimicrobial Agents and Chemotherapy and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.